Nevertheless, dysregulated p16–CDK4/6–cyclinD1 signaling is a well-known common event in the pathogenesis of NPC that promotes uncontrolled tumor growth and metastasis. The gene discussed is CDKN2A; the disease is nasopharyngeal carcinoma.